Search
Showing results for "1"
News & Events
Launching TRACE T1DWe are excited to launch this first-of-its-kind Australian study, monitoring glucose levels in Australian children and adolescents who have tested positive to having one or more type 1 diabetes related antibodies but do not yet need treatment with insulin.
Research
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptomsHLA-A*32:01 is strongly associated with vancomycin-induced DRESS in a population of predominantly European ancestry
Research
Pediatric hospital admissions in Indigenous children: A population-based study in remote AustraliaWe analysed hospital admissions of a predominantly Aboriginal cohort of children in the remote Fitzroy Valley in Western Australia during their first 7 years.
Research
Is it still correct to differentiate between early and very early onset psychosis?Larger samples of patients are needed to better understand if the differentiation between very early onset psychosis and early onset psychosis is justified
Research
Cellular and molecular changes to cortical neurons following low intensity repetitive magnetic stimulation at different frequenciesA systematic comparison of the cellular and molecular changes in neurons in vitro induced by low intensity magnetic stimulation at different frequencies.
News & Events
Hybrid Closed Loop and Difficult Foods StudyManaging blood glucose levels with different foods can be challenging. Our research team would like to know how the hybrid closed loop system, deals with these foods, compared to standard pump therapy.
News & Events
National Community and Consumer Involvement Committee UpdateNational committee members are a really important part of our research projects. Find out what they have been working on.
Read about the management staff of the Children's Diabetes Centre, Dr Charles Czank and Nirubasini Paramalingam.
Research
Barriers and Considerations for Diagnosing Rare Diseases in Indigenous PopulationsAdvances in omics and specifically genomic technologies are increasingly transforming rare disease diagnosis. However, the benefits of these advances are disproportionately experienced within and between populations, with Indigenous populations frequently experiencing diagnostic and therapeutic inequities. The International Rare Disease Research Consortium (IRDiRC) multi-stakeholder partnership has been advancing toward the vision of all people living with a rare disease receiving an accurate diagnosis, care, and available therapy within 1 year of coming to medical attention. In order to further progress toward this vision, IRDiRC has created a taskforce to explore the access barriers to diagnosis of rare genetic diseases faced by Indigenous peoples, with a view of developing recommendations to overcome them.
Research
Evaluation of a public education campaign to support parents to reduce adolescent alcohol useThe Parents, Young People and Alcohol campaign achieved high awareness and positively influenced parental outcomes